ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vyome Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.109 -- 00:00:05.012 Good afternoon and thank you for joining the Reshape Life Sciences First Quarter 2024 00:00:05.012 -- 00:00:10.794 Conference Call. I would like to turn the call over to Michael Miller from RX Communications. 00:00:12.036 -- 00:00:16.879 Good afternoon and thank you for joining the First Quarter 2024 Reshape Life Sciences 00:00:16.879 -- 00:00:21.662 Earnings Call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive 00:00:21.662 -- 00:00:25.584 Officer, and Tom Stankovic, Chief Financial Officer. 00:00:25.584 -- 00:00:29.960 Paul will provide an overview and update on the company's activities and Tom will review 00:00:29.960 -- 00:00:34.083 the financial results for the period. We will then turn the call back over to Paul for 00:00:34.083 -- 00:00:40.048 some closing remarks, after which we will open up the call to question and answer session. 00:00:40.048 -- 00:00:45.572 As a reminder, this conference call, as well as Reshape Life Sciences SEC filings 00:00:45.572 -- 00:00:50.796 and website, including the investor information section of the website, contains forward-looking 00:00:50.796 -- 00:00:56.377 statements within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:56.377 -- 00:01:01.060 Actual results could differ materially from those discussed due to known and unknown 00:01:01.060 -- 00:01:06.104 risks, uncertainties, and other factors. These and additional risks and uncertainties 00:01:06.104 -- 00:01:11.007 are described more fully in the company's filings with the Securities and Exchange Commission, 00:01:11.007 -- 00:01:16.491 including those factors identified as risk factors in the company's most recent annual 00:01:16.491 -- 00:01:21.655 report on Form 10-K. As an ad...